Literature DB >> 15305330

Detecting epistatic interactions contributing to quantitative traits.

Robert Culverhouse1, Tsvika Klein, William Shannon.   

Abstract

The restricted partition method (RPM) is a partitioning algorithm for examining multi-locus genotypes as (potentially non-additive) predictors of a quantitative trait. The motivating application was to develop a robust method to examine quantitative phenotypes for epistasis (gene-gene interactions), but the method can be applied without modification to gene-environment interactions. Simulation results indicate that the method provides an efficient way to identify loci contributing epistatically to a quantitative trait, even if the loci have no single locus effects. Statistical significance can be estimated through permutation testing. An example using real data involving the metabolism of a chemotherapy drug is included for illustration. Although the examples in this article involve 2-locus interactions, the RPM is computationally feasible for the analysis of more than two loci or factors.

Mesh:

Year:  2004        PMID: 15305330     DOI: 10.1002/gepi.20006

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  75 in total

1.  A novel bayesian graphical model for genome-wide multi-SNP association mapping.

Authors:  Yu Zhang
Journal:  Genet Epidemiol       Date:  2011-11-29       Impact factor: 2.135

2.  Understanding the Evolutionary Process of Grammatical Evolution Neural Networks for Feature Selection in Genetic Epidemiology.

Authors:  Alison A Motsinger; David M Reif; Scott M Dudek; Marylyn D Ritchie
Journal:  Proc IEEE Symp Comput Intell Bioinforma Comput Biol       Date:  2006-09-28

3.  Uncovering hidden variance: pair-wise SNP analysis accounts for additional variance in nicotine dependence.

Authors:  Robert C Culverhouse; Nancy L Saccone; Jerry A Stitzel; Jen C Wang; Joseph H Steinbach; Alison M Goate; Tae-Hwi Schwantes-An; Richard A Grucza; Victoria L Stevens; Laura J Bierut
Journal:  Hum Genet       Date:  2010-11-16       Impact factor: 4.132

Review 4.  Large recursive partitioning analysis of complex disease pharmacogenetic studies. II. Statistical considerations.

Authors:  Dmitri V Zaykin; S Stanley Young
Journal:  Pharmacogenomics       Date:  2005-01       Impact factor: 2.533

5.  Candidate genes and their regulatory elements: alcohol preference and tolerance.

Authors:  Laura Saba; Sanjiv V Bhave; Nicholas Grahame; Paula Bice; Razvan Lapadat; John Belknap; Paula L Hoffman; Boris Tabakoff
Journal:  Mamm Genome       Date:  2006-06-12       Impact factor: 2.957

6.  Contrasting linkage-disequilibrium patterns between cases and controls as a novel association-mapping method.

Authors:  Dmitri V Zaykin; Zhaoling Meng; Margaret G Ehm
Journal:  Am J Hum Genet       Date:  2006-03-13       Impact factor: 11.025

7.  Individual odortypes: interaction of MHC and background genes.

Authors:  Alan Willse; Jae Kwak; Kunio Yamazaki; George Preti; Jon H Wahl; Gary K Beauchamp
Journal:  Immunogenetics       Date:  2006-11-07       Impact factor: 2.846

8.  A Bayesian multilocus association method: allowing for higher-order interaction in association studies.

Authors:  Anders Albrechtsen; Sofie Castella; Gitte Andersen; Torben Hansen; Oluf Pedersen; Rasmus Nielsen
Journal:  Genetics       Date:  2007-04-15       Impact factor: 4.562

9.  Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels.

Authors:  Ana M Coutinho; Inês Sousa; Madalena Martins; Catarina Correia; Teresa Morgadinho; Celeste Bento; Carla Marques; Assunção Ataíde; Teresa S Miguel; Jason H Moore; Guiomar Oliveira; Astrid M Vicente
Journal:  Hum Genet       Date:  2007-01-03       Impact factor: 4.132

10.  Finding unique filter sets in PLATO: a precursor to efficient interaction analysis in GWAS data.

Authors:  Benjamin J Grady; Eric Torstenson; Scott M Dudek; Justin Giles; David Sexton; Marylyn D Ritchie
Journal:  Pac Symp Biocomput       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.